Word

MYTIRAZ

Status

Dead

Status Code

604

Status Date

Thursday, October 10, 2013

Serial Number

85729516

Mark Type

4000

Filing Date

Friday, September 14, 2012

Published for Opposition

Tuesday, February 26, 2013

Abandoned Date

Thursday, October 10, 2013

Trademark Owner History

Glaxo Group Limited - Owner At Publication

Classifications

5 (Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

MY TIRAZ

Trademark Events

Oct 10, 2013

Abandonment Notice Mailed - Inter Partes Decision

Oct 10, 2013

Abandonment - After Inter Partes Decision

Oct 10, 2013

Opposition Terminated No. 999999

Oct 10, 2013

Opposition Dismissed No. 999999

Jun 25, 2013

Opposition Instituted No. 999999

Mar 28, 2013

Extension Of Time To Oppose Received

Mar 25, 2013

Applicant/Correspondence Changes (Non-Responsive) Entered

Mar 25, 2013

Teas Change Of Owner Address Received

Feb 26, 2013

Official Gazette Publication Confirmation E-Mailed

Feb 26, 2013

Published For Opposition

Feb 6, 2013

Notification Of Notice Of Publication E-Mailed

Jan 22, 2013

Electronic Record Review Complete

Jan 18, 2013

On Hold - Electronic Record Review Required

Jan 9, 2013

Approved For Pub - Principal Register

Jan 7, 2013

Assigned To Examiner

Sep 21, 2012

Notice Of Pseudo Mark Mailed

Sep 20, 2012

New Application Office Supplied Data Entered In Tram

Sep 18, 2012

New Application Entered In Tram